Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03727984
Other study ID # 2018-2
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 15, 2018
Est. completion date November 15, 2019

Study information

Verified date January 2020
Source Cardiovascular Academy Society, Turkey
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The predictors of re-hospitalization of patients with history of acute coronary syndrome


Description:

The aim of this retrospective multicenter study is to evaluate the demographic, clinical characteristics and medications of re-hospitalized for new cardiac event in patients with history of acute coronary syndrome within in 12 months.


Recruitment information / eligibility

Status Completed
Enrollment 577
Est. completion date November 15, 2019
Est. primary completion date September 15, 2019
Accepts healthy volunteers
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

Patients age >18 years who had hospitalized for acute coronary syndrome within 12 months

Exclusion Criteria:

Patients whose previous hospitalizations data are not available Myocardial Infarction, type 2 patients

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Cardiovascular Academy Society Izmir

Sponsors (1)

Lead Sponsor Collaborator
Cardiovascular Academy Society, Turkey

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical and demographics characteristics of patients re-admitted with acute coronary syndrome The demographics and clinical characteristics of study population Admissions with an 'I'-group ICD-10 code Up to 1 year
Primary Cardiovascular Hospitalization Predictive factors for patients re-admitted with acute coronary Up to 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06013813 - Conventional vs. Distal Radial Access Outcomes in STEMI Patients Treated by PCI N/A
Recruiting NCT05412927 - AngelMed Guardian® System PMA Post Approval Study
Completed NCT02750579 - Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes? N/A
Completed NCT04102410 - Assessing Force-velocity Profile: an Innovative Approach to Optimize Cardiac Rehabilitation in Coronary Patients N/A
Enrolling by invitation NCT03342131 - Serum Concentration of Wnt2 and Wnt4 in Patients With Acute Coronary Syndrome N/A
Recruiting NCT01218776 - International Survey of Acute Coronary Syndromes in Transitional Countries
Enrolling by invitation NCT04676100 - International CR Registry
Completed NCT03590535 - 5th Generation cTnT in ED ACS
Recruiting NCT05437900 - INSIGHTFUL-FFR Clinical Trial Phase 4
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Terminated NCT04316481 - IDE-ALERTS Continued Access Study N/A
Active, not recruiting NCT04475380 - Complex All-comers and Patients With Diabetes or Prediabetes, Treated With Xience Sierra Everolimus-eluting Stents
Not yet recruiting NCT04852146 - Electronic Feedback for Data Restitution and Valorization to the Emergency Teams in Aquitaine.
Active, not recruiting NCT02892903 - In the Management of Coronary Artery Disease, Does Routine Pressure Wire Assessment at the Time of Coronary Angiography Affect Management Strategy, Hospital Costs and Outcomes? N/A
Completed NCT04077229 - Piloting Text Messages to Promote Positive Affect and Physical Activity N/A
Not yet recruiting NCT02871622 - BMX Alpha Registry: a Post-market Registry of the BioMatrix Alpha TM N/A
Completed NCT02944123 - Half Dose of Prasugrel and Ticagrelor in Acute Coronary Syndrome (HOPE-TAILOR) Phase 3
Active, not recruiting NCT02922140 - The Impact of Pharmaceutical Care Practice on Patients in Cardiac Rehabilitation Unit N/A
Completed NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study